Catalyst Wire Dossier Catalyst Wire Dossier

Pure Green sublingual cannabinoid tablets (investigational)

· Pure Green
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pure Green sublingual cannabinoid tablets (investigational), covering 2019-09-19 to 2019-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea [Phase 2]

See pricing